- Home
- Profiles
![Mount Sinai Logo](https://www.mountsinai.org/mshealth/themes/default/media/images/logo-color.png)
![Scott Weingart](https://www.mountsinai.org/files/fad_img_new/159/0000076810011253717571/0000072500001497154782.jpg)
Scott Weingart, MD
- About Me
- Education & Certifications
- Locations
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Education
MD, Mount Sinai School of Medicine
, Cabrini Medical Center, Mount Sinai School of Medicine
, Mount Sinai School of Medicine
, University of Maryland Medical Center
Locations
Publications
Selected Publications
- Managing Emergency Endotracheal Intubation Utilizing a Bougie. Ryan N. Barnicle, Alexander Bracey, Scott D. Weingart. Annals of Emergency Medicine
- Exploration of Norepinephrine Dose-Capping Practices: Report From an International, Interprofessional Survey of Critical Care Clinicians. Susan E. Smith, Stephen Perona, Scott D. Weingart. Journal of Pharmacy Practice
- A taxonomy of key performance errors for emergency intubation. Scott D. Weingart, Ryan N. Barnicle, Alexander Janke, Sabrina D. Bhagwan, Matthew Tanzi, Peter J. McKenna, Alexander Bracey. American Journal of Emergency Medicine
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Weingart has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Weingart has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.